Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.

By S. Mazurek. International Journal of Biochemistry and Cell Biology, 2011

683 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Neurology

View Paper: https://www.semanticscholar.org/paper/335ab3c4573e432c9ad1b883ec2c1de6607fb42c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Patrick S. Ward
2. Craig B. Thompson
3. Ralph J. Deberardinis
4. M. V. Vander Heiden
5. Navdeep S. Chandel
6. Jason W. Locasale
7. Alec C. Kimmelman
8. C. V. Dang

In Molecular Biology

1. Patrick S. Ward
2. Craig B. Thompson
3. Ralph J. Deberardinis
4. M. V. Vander Heiden
5. David M. Sabatini
6. Navdeep S. Chandel
7. Jason W. Locasale
8. Guido Kroemer

In Neurology

1. Craig B. Thompson
2. Patrick S. Ward

Citations in the corpus

• Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012, background): “Oncometabolite 2-Hydroxyglutarate While the preference for all tumor cells to express PKM2 versus PKM1 is striking and likely selected for to facilitate anabolic metabolism, PKM2 is present in most proliferating cells and is not specific to cancer (Mazurek, 2011).”